These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Cyclodextrin, a novel therapeutic tool for suppressing amyloidogenic transthyretin misfolding in transthyretin-related amyloidosis. Jono H; Anno T; Motoyama K; Misumi Y; Tasaki M; Oshima T; Mori Y; Mizuguchi M; Ueda M; Shono M; Obayashi K; Arima H; Ando Y Biochem J; 2011 Jul; 437(1):35-42. PubMed ID: 21668413 [TBL] [Abstract][Full Text] [Related]
23. Clusterin regulates transthyretin amyloidosis. Lee KW; Lee DH; Son H; Kim YS; Park JY; Roh GS; Kim HJ; Kang SS; Cho GJ; Choi WS Biochem Biophys Res Commun; 2009 Oct; 388(2):256-60. PubMed ID: 19664600 [TBL] [Abstract][Full Text] [Related]
24. Genistein, a natural product from soy, is a potent inhibitor of transthyretin amyloidosis. Green NS; Foss TR; Kelly JW Proc Natl Acad Sci U S A; 2005 Oct; 102(41):14545-50. PubMed ID: 16195386 [TBL] [Abstract][Full Text] [Related]
26. Effect of the intestinal flora on amyloid deposition in a transgenic mouse model of familial amyloidotic polyneuropathy. Noguchi H; Ohta M; Wakasugi S; Noguchi K; Nakamura N; Nakamura O; Miyakawa K; Takeya M; Suzuki M; Nakagata N; Urano T; Ono T; Yamamura K Exp Anim; 2002 Jul; 51(4):309-16. PubMed ID: 12221923 [TBL] [Abstract][Full Text] [Related]
28. Aging and transthyretin-related amyloidosis: pathologic examinations in pulmonary amyloidosis. Ueda M; Ando Y; Haraoka K; Katsuragi S; Terasaki Y; Sugimoto M; Sun X; Uchino M Amyloid; 2006 Mar; 13(1):24-30. PubMed ID: 16690497 [TBL] [Abstract][Full Text] [Related]
29. A mouse model of a novel missense mutation (Gly83Arg) in a Chinese kindred manifesting vitreous amyloidosis only. Ran LX; Zheng ZY; Xie B; Nie XM; Chen XW; Su G; Cai SJ Exp Eye Res; 2018 Apr; 169():13-19. PubMed ID: 29360446 [TBL] [Abstract][Full Text] [Related]
30. Inconsistency between hepatic expression and serum concentration of transthyretin in mice humanized at the transthyretin locus. Zhao G; Li Z; Araki K; Haruna K; Yamaguchi K; Araki M; Takeya M; Ando Y; Yamamura K Genes Cells; 2008 Dec; 13(12):1257-68. PubMed ID: 19032346 [TBL] [Abstract][Full Text] [Related]
31. Cys-10 mixed disulfide modifications exacerbate transthyretin familial variant amyloidogenicity: a likely explanation for variable clinical expression of amyloidosis and the lack of pathology in C10S/V30M transgenic mice? Zhang Q; Kelly JW Biochemistry; 2005 Jun; 44(25):9079-85. PubMed ID: 15966731 [TBL] [Abstract][Full Text] [Related]
32. Significant deposition of wild type transthyretin-derived amyloid in the gastrointestinal tract of aged individuals. Ikeda S; Tojo K; Suzuki-Tsuchiya A; Akamatu T; Hashimoto T; Higuchi K Amyloid; 2009; 16(3):174-7. PubMed ID: 19626481 [TBL] [Abstract][Full Text] [Related]
33. Progression of cardiac amyloid deposition in hereditary transthyretin amyloidosis patients after liver transplantation. Liepnieks JJ; Benson MD Amyloid; 2007 Dec; 14(4):277-82. PubMed ID: 17968687 [TBL] [Abstract][Full Text] [Related]
34. Specific disruption of transthyretin(105-115) fibrilization using "stabilizing" inhibitors of transthyretin amyloidogenesis. Liang Y; Ore MO; Morin S; Wilson DJ Biochemistry; 2012 Apr; 51(16):3523-30. PubMed ID: 22482799 [TBL] [Abstract][Full Text] [Related]